Elemental Impurities in Botanical Tinctures: What Analytical Testing Laboratories Find That Powder Testing Misses

Most of the supplement brands we work with test their botanical raw materials in powder form. They get a CoA, the ICP-MS numbers look clean, and the purchase order goes through. Then six months later, the finished tincture shows up on a retailer’s compliance portal with a Prop 65 lead flag.

The math was never wrong. The testing protocol was.

USP <232> and <233> — which replaced the outdated colorimetric heavy metals test (USP <231>) for new dietary supplement products starting around 2018 — apply to finished dosage forms, not just raw materials. And when the dosage form is a liquid botanical extract, tincture, or glycerite, the rules governing how you calculate compliance change in ways that catch a surprising number of Midwest brands off-guard.

This is what analytical testing laboratories regularly find when they screen botanical tinctures — and what your current raw material CoA almost certainly isn’t telling you.

Why Liquid Matrices Play by Different Rules Under USP <232>/<233>

The USP <232>/<233> framework is built around Permitted Daily Exposures — the maximum daily elemental intake considered acceptable based on toxicological thresholds. For oral products, the Class 1 PDE limits are: lead at 5 μg/day, arsenic at 15 μg/day, cadmium at 2 μg/day, and mercury at 3 μg/day.

Notice the unit: micrograms per day, not micrograms per gram of material. This is the fundamental shift that trips up powder-centric testing programs. When you’re assessing a hard capsule or tablet, the per-dose elemental load is relatively straightforward — multiply the elemental concentration in the blend by the serving weight. A 600 mg capsule with 0.3 ppm lead carries 0.18 μg of lead per dose. Simple.

Liquid extracts complicate this in two ways.

First, the extraction ratio. A traditional herbal tincture is typically prepared at a 1:4 or 1:5 plant-to-solvent ratio — one part dried herb to four parts ethanol-water. That means 1 mL of finished tincture contains the elemental load derived from approximately 200–250 mg of the original herb. A standard 2 mL daily dose effectively delivers the elemental burden of 400–500 mg of raw botanical. If the raw material carries 0.5 ppm lead, that dose may contribute roughly 0.2–0.25 μg of lead before any extraction efficiency adjustments.

That still sounds safe against the 5 μg/day USP PDE. But the second factor is where things get complicated: not all elements extract equally into the liquid phase. Certain metals — particularly lead, arsenic in its inorganic forms, and cadmium — show measurable affinity for the polyphenol-rich aqueous-ethanol matrices common in botanical extracts. The partitioning behavior of inorganic arsenic between a plant matrix and a 40% ethanol solution can result in 60–80% extraction efficiency, meaning the liquid concentrate may carry proportionally more inorganic arsenic than a simple weight-based calculation would suggest.

This is exactly why testing the tincture directly — rather than back-calculating from the raw powder CoA — is the only defensible approach under USP <233>.

The California Prop 65 Reality Check That Changes the Math

Here’s where Midwest supplement brands get caught. You’re formulating in Illinois. You’re compliant with USP <232>/<233>. Your finished tincture delivers well under 5 μg/day of lead. Good.

Then your products hit Amazon or a national natural foods retailer, and California becomes your de facto compliance standard. California Proposition 65’s Maximum Allowable Dose Level for lead — specifically for reproductive toxicity — is 0.5 μg/day. That’s exactly one-tenth the USP oral PDE.

That’s not a rounding difference. It’s an order-of-magnitude gap. A product that sails through USP <232>/<233> review can simultaneously require a Prop 65 warning label without any change to the formulation.

We see this pattern consistently when testing tinctures made from high-lead-risk botanicals: licorice root (Glycyrrhiza glabra), valerian root (Valeriana officinalis), and certain Ayurvedic formulations including Triphala blends. Lead in soil accumulates preferentially in root tissue compared to aerial plant parts, and root-based tinctures reflect that bioaccumulation. Published data on licorice root shows lead concentrations ranging from 0.08 to 1.2 ppm depending on growing region — and Chinese-sourced material, which dominates North American supply chains, trends toward the higher end of that range.

At 1.2 ppm lead in the raw botanical, a 2 mL daily dose of a 1:4 licorice tincture delivers approximately 0.6 μg of lead — already above the Prop 65 MADL, even before factoring extraction efficiency above 50%. The brand sourcing that material and running only a powder CoA review would never see that exposure on paper.

The brands that catch this before the retailer does are running ICP-MS on the finished tincture, not just the incoming herb.

What Analytical Testing Laboratories Actually Find When Running Tincture Matrices

Running ICP-MS on liquid botanical extracts introduces real analytical challenges that separate rigorous analytical testing laboratories from those simply applying their dried-powder protocol to a liquid sample.

Ethanol in tinctures depresses plasma temperature in the ICP torch and generates carbon-based spectral interferences if the sample isn’t properly prepared. Glycerites — tinctures using vegetable glycerin instead of ethanol — present their own matrix suppression issues from high viscosity and elevated organic load. A lab running an underprepared tincture sample may see falsely low elemental readings. That’s worse than a false high. It creates confidence that the product is clean when it isn’t.

A proper analytical protocol for botanical tincture analysis under USP <233> includes:

• Microwave-assisted acid digestion to destroy the organic matrix and liberate all elemental species from both the plant matter and the solvent phase
• Internal standard selection using elements unlikely to appear in the sample — typically rhodium-103 and iridium-191 — to correct for signal drift throughout the run
• Matrix-matched calibration to aqueous standards adjusted to reflect the digested sample composition, not simple aqueous blanks
• Spike recovery verification at 80–120% for each target element before results are reported

Beyond the total elemental panel, we also run arsenic speciation when the botanical matrix warrants it. Inorganic arsenic (As³⁺ and As⁵⁺) is the regulated form under most frameworks, including Prop 65 and USP <232>. Organic arsenicals like arsenobetaine and arsenocholine, common in marine-derived botanicals, are far less toxic and typically excluded from regulatory calculations. For kelp, spirulina, or chlorella-containing liquid supplements, total arsenic numbers can look alarming on an unspeciated panel — but the inorganic fraction may represent only 5–15% of that total. Conversely, some terrestrial herbal extracts carry disproportionately high inorganic arsenic fractions despite modest total arsenic levels. Without speciation, you’re making compliance decisions on incomplete data.

Building a Compliant Elemental Impurities Protocol for Liquid Products

If your current SOP involves testing the raw botanical powder, reviewing a supplier CoA, and treating that as clearance for your tincture production run, the gap in your program is structural. Here’s how to close it.

Step one: test the finished dosage form. USP <232>/<233> compliance is assessed at the finished product level. Your raw material CoA supports identity and strength verification under 21 CFR Part 111.75 — it doesn’t satisfy the elemental impurities assessment for the finished liquid. Engage an analytical testing laboratory with ISO 17025 accreditation to run a full Class 1 and 2A elemental panel on the finished tincture. The accreditation matters — it means measurement uncertainty is validated and results carry regulatory weight under DSHEA enforcement.

Step two: calculate against your actual daily dose. Pull the daily serving size from your label in milliliters. Multiply the elemental concentration in μg/mL by that volume. Compare that number to the USP <232> oral PDEs and, if you sell in California or through Amazon, against the Prop 65 MADLs. If you’re within 2× of the Prop 65 MADL for lead, act before a retailer compliance test triggers it for you.

Step three: assess your container-closure contribution. Amber glass bottles — the standard for herbal tinctures — are generally low-risk. But not all glass is equal. Soda-lime glass under mildly acidic conditions can leach trace elements over shelf life, and low-quality borosilicate from non-certified suppliers has been documented to contribute measurable lead in long-stability studies. Plastic dropper assemblies deserve a review of your supplier’s extractable and leachable data. This rarely dominates the elemental profile but belongs in a complete USP <232>/<233> risk assessment.

Step four: build finished-product elemental limits into your spec sheet. Under 21 CFR Part 111.70, every dietary supplement must have a written product specification covering identity, purity, strength, and composition. For a liquid product, that specification should include elemental impurity acceptance criteria based on the daily dose calculation — not just the raw material spec. An FDA inspection or third-party audit that finds a liquid product spec without finished-product elemental limits is going to generate an observation.

Step five: choose botanical sources with documented provenance. The fastest way to reduce elemental impurity risk in tinctures is sourcing from farms with documented low-metal soil backgrounds. Certified Organic status doesn’t mean low heavy metals — it means pesticide-free. Organic-certified botanicals from high-arsenic or high-cadmium growing regions fail heavy metals specifications at a rate that would surprise most brand formulators. Require a full USP <232>/<233>-compliant CoA from your supplier and verify it against your own incoming analytical testing rather than trusting it at face value.

The Brands That Get This Right Have a Real Competitive Advantage

There’s a commercial dimension here beyond compliance. Whole Foods, iHerb, and Thrive Market have been tightening incoming quality requirements for liquid supplement products, and the trend is toward requiring finished-product ICP-MS CoAs — not just raw material documentation. NSF International’s Certified for Sport program and USP’s Dietary Supplement Verification Program both require finished-product elemental testing. As these third-party marks become table stakes for placement in premium retail channels, a documented, validated tincture elemental testing protocol becomes a sourcing and distribution advantage, not just a regulatory checkbox.

Brands that treat analytical testing as part of product development — rather than a post-formulation hurdle — consistently get into new retail channels faster. And they’re significantly more resilient when FDA sends a warning letter to a competitor in their category, because their own records are already defensible.

The work of getting it right here is specific and methodological. But it’s not complicated if you understand what a proper tincture ICP-MS protocol looks like and you’re working with an analytical testing laboratory that runs these matrices routinely.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025-Accredited Heavy Metals Testing for Dietary Supplements — Full USP <232>/<233> elemental impurity panels and California Prop 65 compliance screening for raw materials and finished products.
• Raw Material CoA Verification and Incoming Testing Programs — How Qalitex Laboratories structures incoming quality testing for Midwest supplement manufacturers, from ICP-MS to identity verification.